Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks-Reference-Cited by-同舟云学术

Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks

Published:2019-05 Issue:5 Volume:139 Page:1054-1062
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

von Stebut Esther,Reich Kristian,Thaçi Diamant,Koenig Wolfgang,Pinter Andreas,Körber Andreas,Rassaf Tienush,Waisman Ari,Mani Venkatesh,Yates Denise,Frueh Jennifer,Sieder Christian,Melzer Nima,Mehta Nehal N.,Gori Tommaso

Funder

Novartis Pharma GmbH, Germany

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference45 articles.

1. Complex reference values for endocrine and special chemistry biomarkers across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey;Adeli;Clin Chem,2015

2. 2. Classification and diagnosis of diabetes;Diabetes Care,2017

3. Epidemiology and comorbidity of psoriasis in children;Augustin;Br J Dermatol,2010

4. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany;Augustin;Acta Derm Venereol,2010

5. Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis;Avgerinou;Int J Cardiol,2011

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do interleukin-17 and interleukin-23 inhibitors alter the coagulation parameters in psoriasis patients?: A retrospective study;Archives of Dermatological Research;2024-09-11

2. Endothelial Dysfunction in Psoriasis: An Integrative Review;Journal of Investigative Dermatology;2024-09

3. Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review;Journal of Clinical Epidemiology;2024-09

4. IL-17 inhibitors in axial spondyloarthritis. An overview;Expert Opinion on Biological Therapy;2024-08-21

5. Associations of different inflammatory factors with atherosclerosis among patients with psoriasis vulgaris;Frontiers in Medicine;2024-07-22